NCT01657942 - Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2019

Study Completion Date

May 31, 2021

Conditions

Localized Intermediate Risk Prostate Lesions

Interventions

DEVICE

ExAblate MR Guided Focused Ultrasound

ExAblate MR Guided Focused Ultrasound - Local treatment of prostate lesions using Magnetic Resonance Imaging guided endorectally applied focused ultrasound energy.

Trial Locations (9)

10021

Weill Cornell Medical Center, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

22908

University of Virginia, Charlottesville

33445

Sperling Prostate Center, Delray Beach

55905

Mayo Clinic, Rochester

90095

University of California Los Angeles, Los Angeles

91010

City of Hope, Duarte

94305

Stanford University School of Medicine, Stanford

02115

Brigham & Women's Hospital, Boston